Could a common anesthetic gas help ICU patients breathe better on ventilators?

NCT ID NCT06014138

First seen Jun 08, 2026 · Last updated Jun 23, 2026 · Updated 4 times

Summary

This study looks at how different sedatives affect the breathing of patients with acute respiratory distress syndrome (ARDS) who are on a ventilator. Twenty adults in the ICU will receive both standard intravenous propofol and inhaled isoflurane (a gas used in anesthesia) for short periods. Researchers will measure breathing drive and effort to see if one approach helps patients breathe more naturally while on the machine.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for ACUTE RESPIRATORY DISTRESS SYNDROME are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • Guy's & St Thomas' NHS Foundation Trust

    RECRUITING

    London, London, SE1 9RT, United Kingdom

    Contact Phone: •••-•••-•••• Email: •••••@•••••

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance

Isoflurane (inhaled volatile sedation) compared to propofol (intravenous sedation)

What this could lead to

If it works, this could point toward better sedation methods that preserve natural breathing in ICU patients with lung injury.

What could go wrong

This is a very small early-phase study with only 20 participants, so results may not apply broadly. The intervention is short-term and only measures physiological changes, not long-term outcomes.

Conditions

The condition(s) this trial relates to.

acute respiratory distress syndrome adult acute respiratory distress syndrome

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.